Free Trial
NASDAQ:NAGE

Niagen Bioscience (NAGE) Stock Price, News & Analysis

Niagen Bioscience logo
$9.88 -0.02 (-0.20%)
As of 09/2/2025 04:00 PM Eastern

About Niagen Bioscience Stock (NASDAQ:NAGE)

Key Stats

Today's Range
$9.50
$9.93
50-Day Range
$9.04
$14.41
52-Week Range
$3.10
$14.69
Volume
613,307 shs
Average Volume
1.06 million shs
Market Capitalization
$787.93 million
P/E Ratio
47.05
Dividend Yield
N/A
Price Target
$13.42
Consensus Rating
Buy

Company Overview

Niagen Bioscience Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
43rd Percentile Overall Score

NAGE MarketRank™: 

Niagen Bioscience scored higher than 43% of companies evaluated by MarketBeat, and ranked 715th out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Niagen Bioscience has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Niagen Bioscience has only been the subject of 3 research reports in the past 90 days.

  • Read more about Niagen Bioscience's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Niagen Bioscience is 47.05, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 269.20.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Niagen Bioscience is 47.05, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 82.98.

  • Price to Book Value per Share Ratio

    Niagen Bioscience has a P/B Ratio of 12.35. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for NAGE.
  • Dividend Yield

    Niagen Bioscience does not currently pay a dividend.

  • Dividend Growth

    Niagen Bioscience does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for NAGE.
  • News Sentiment

    Niagen Bioscience has a news sentiment score of 0.72. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.96 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Niagen Bioscience this week, compared to 3 articles on an average week.
  • Search Interest

    9 people have searched for NAGE on MarketBeat in the last 30 days. This is an increase of 125% compared to the previous 30 days.
  • MarketBeat Follows

    Only 4 people have added Niagen Bioscience to their MarketBeat watchlist in the last 30 days. This is a decrease of -71% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Niagen Bioscience insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 9.39% of the stock of Niagen Bioscience is held by insiders.

  • Percentage Held by Institutions

    Only 15.41% of the stock of Niagen Bioscience is held by institutions.

  • Read more about Niagen Bioscience's insider trading history.
Receive NAGE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Niagen Bioscience and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NAGE Stock News Headlines

One tiny company just cracked Google’s $19B problem
For decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. Then an MIT team cracked the code… dropping the cost from $63,000 to just 90 cents per gram. Now, one US-based factory is gearing up to supply the AI, aerospace, and EV industries with the one material they can’t continue to grow without. Only one company controls it, and its stock is still flying under Main Street’s radar.tc pixel
Unlocking Cellular Health With Science and Trust
See More Headlines

NAGE Stock Analysis - Frequently Asked Questions

Niagen Bioscience's stock was trading at $5.48 at the beginning of the year. Since then, NAGE stock has increased by 80.3% and is now trading at $9.88.

Niagen Bioscience, Inc. (NASDAQ:NAGE) announced its quarterly earnings results on Wednesday, August, 6th. The company reported $0.04 EPS for the quarter, topping analysts' consensus estimates of $0.02 by $0.02. The firm earned $31.12 million during the quarter, compared to analyst estimates of $28.55 million. Niagen Bioscience had a net margin of 15.24% and a trailing twelve-month return on equity of 23.12%.

Shares of NAGE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/06/2025
Today
9/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:NAGE
Previous Symbol
NASDAQ:NAGE
CIK
1386570
Web
N/A
Employees
120
Year Founded
N/A

Price Target and Rating

High Price Target
$23.00
Low Price Target
$8.00
Potential Upside/Downside
+35.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.21
Trailing P/E Ratio
47.05
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$8.55 million
Net Margins
15.24%
Pretax Margin
15.76%
Return on Equity
23.12%
Return on Assets
15.53%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.88
Quick Ratio
3.24

Sales & Book Value

Annual Sales
$99.60 million
Price / Sales
7.91
Cash Flow
$0.06 per share
Price / Cash Flow
167.37
Book Value
$0.80 per share
Price / Book
12.35

Miscellaneous

Outstanding Shares
79,750,000
Free Float
72,264,000
Market Cap
$787.93 million
Optionable
N/A
Beta
2.21
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:NAGE) was last updated on 9/3/2025 by MarketBeat.com Staff
From Our Partners